Normal Values for <sup>13</sup>N-Ammonia PET-derived Metrics in Heart Transplant Patients
Listen to this summary
The authors aimed to establish normal reference values for myocardial blood flow (MBF), myocardial blood flow reserve (MBFR), and left ventricular parameters in heart transplant (HT) recipients using <sup>13</sup>N-ammonia PET imaging. By evaluating 266 HT recipients and comparing results from two software programs, they found that while there was a strong relationship between metrics, the agreement was moderate to good, highlighting the importance of software-specific thresholds for assessing cardiac health in transplant patients.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
View all →Jul 3, 2026 · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Clinical Application and Research Advances of PET Molecular Imaging in Immune Checkpoint Inhibitor-Associated Myocarditis
Jul 2, 2026 · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Immuno-PET in Cardiovascular Disease: Advances, Challenges, and Opportunities
Jun 9, 2026 · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
PROGNOSTIC IMPACT OF MYOCARDIAL FLOW RESERVE ASSESSED BY CZT-SPECT
Jun 9, 2026 · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Radiation dosimetry of <sup>15</sup>O-water based on dynamic large axial field of view PET
Jun 4, 2026 · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Right Ventricular Metabolic Adaptation to Afterload and Heterogeneous RV-Pulmonary Arterial Coupling in Pre-Capillary Pulmonary Hypertension: An FDG-PET/CMR Study
More in Nuclear Medicine
View all →Jul 10, 2026 · Lancet (London, England)
Advancing the relevance of clinical trials for older patients
Jul 9, 2026 · Lancet (London, England)
Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial
Jul 9, 2026 · Lancet (London, England)
Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations
Jul 9, 2026 · Lancet (London, England)
Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial
Jul 8, 2026 · The New England journal of medicine
Nutrition Therapy in Critically Ill Adults
Jul 8, 2026 · Lancet (London, England)
Systemic light chain and transthyretin amyloidosis-treatment advancements and future directions
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
